Faculty of Medical and Health Sciences, University of Auckland, Auckland 1023, New Zealand.
Nutrition Society of New Zealand, Palmerston North 4444, New Zealand.
Nutrients. 2019 Jul 5;11(7):1532. doi: 10.3390/nu11071532.
This review discusses the personalised dietary approach with respect to inflammatory bowel disease (IBD). It identifies gene-nutrient interactions associated with the nutritional deficiencies that people with IBD commonly experience, and the role of the Western diet in influencing these. It also discusses food intolerances and how particular genotypes can affect these. It is well established that with respect to food there is no "one size fits all" diet for those with IBD. Gene-nutrient interactions may help explain this variability in response to food that is associated with IBD. Nutrigenomic research, which examines the effects of food and its constituents on gene expression, shows that-like a number of pharmaceutical products-food can have beneficial effects or have adverse (side) effects depending on a person's genotype. Pharmacogenetic research is identifying gene variants with adverse reactions to drugs, and this is modifying clinical practice and allowing individualised treatment. Nutrigenomic research could enable individualised treatment in persons with IBD and enable more accurate tailoring of food intake, to avoid exacerbating malnutrition and to counter some of the adverse effects of the Western diet. It may also help to establish the dietary pattern that is most protective against IBD.
这篇综述讨论了针对炎症性肠病 (IBD) 的个性化饮食方法。它确定了与 IBD 患者常见的营养缺乏有关的基因-营养相互作用,以及西方饮食在影响这些相互作用中的作用。它还讨论了食物不耐受以及特定基因型如何影响这些相互作用。人们已经充分认识到,对于 IBD 患者来说,没有一种“一刀切”的饮食方法。基因-营养相互作用可能有助于解释与 IBD 相关的对食物反应的这种可变性。营养基因组学研究检查了食物及其成分对基因表达的影响,表明与许多药物一样,食物可能具有有益的影响,也可能具有不良(副作用)影响,具体取决于一个人的基因型。药物遗传学研究正在确定对药物有不良反应的基因变异体,这正在改变临床实践并允许个体化治疗。营养基因组学研究可以使 IBD 患者实现个体化治疗,并能够更准确地调整饮食摄入,避免加重营养不良,并抵消西方饮食的一些不良影响。它还有助于确定最能预防 IBD 的饮食模式。